Drugplain

DALVANCE 500 mg/25mL

Dalbavancin · INJECTION, POWDER, FOR SOLUTION · Allergan, Inc.

No Recall History
Plain English

DALVANCE is a injection, powder, for solution containing dalbavancin at 500 mg/25mL, taken intravenous. Manufactured by Allergan, Inc..

Key Facts

Brand Name
DALVANCE
Generic Name
Dalbavancin
NDC Code (Product)
57970-100
Manufacturer
Allergan, Inc.
Strength
500 mg/25mL
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Marketing Status
Application #
NDA021883
Marketing Start
05/23/2014

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

off label use139 reports
rash95 reports
pruritus58 reports
back pain56 reports
drug ineffective53 reports
dyspnoea53 reports
nausea52 reports
hypersensitivity45 reports
vomiting45 reports
erythema42 reports

Frequently Asked Questions

What is DALVANCE used for?

DALVANCE contains Dalbavancin. It is a injection, powder, for solution taken intravenous. Consult your doctor for specific uses.

Is DALVANCE a controlled substance?

DALVANCE is not classified as a controlled substance by the DEA.

What is the generic name for DALVANCE?

The generic name for DALVANCE is Dalbavancin. There are 4 other brand versions of Dalbavancin.

What is the NDC code for DALVANCE 500 mg/25mL?

The NDC (National Drug Code) for DALVANCE 500 mg/25mL is 57970-100, listed by Allergan, Inc..

Product NDC

57970-100

Package NDC

57970-100-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)